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Genome mining of the mithramycin producer Streptomyces argillaceus ATCC 12956
revealed 31 gene clusters for the biosynthesis of secondary metabolites, and allowed
to predict the encoded products for 11 of these clusters. Cluster 18 (renamed
cluster arp) corresponded to a type I polyketide gene cluster related to the previously
described coelimycin P1 and streptazone gene clusters. The arp cluster consists
of fourteen genes, including genes coding for putative regulatory proteins (a SARP-
like transcriptional activator and a TetR-like transcriptional repressor), genes coding
for structural proteins (three PKSs, one aminotransferase, two dehydrogenases, two
cyclases, one imine reductase, a type II thioesterase, and a flavin reductase), and
one gene coding for a hypothetical protein. Identification of encoded compounds by
this cluster was achieved by combining several strategies: (i) inactivation of the type I
PKS gene arpPIII; (ii) inactivation of the putative TetR-transcriptional repressor arpRII;
(iii) cultivation of strains in different production media; and (iv) using engineered strains
with higher intracellular concentration of malonyl-CoA. This has allowed identifying six
new alkaloid compounds named argimycins P, which were purified and structurally
characterized by mass spectrometry and nuclear magnetic resonance spectroscopy.
Some argimycins P showed a piperidine ring with a polyene side chain (argimycin
PIX); others contain also a fused five-membered ring (argimycins PIV-PVI). Argimycins
PI-PII showed a pyridine ring instead, and an additional N-acetylcysteinyl moiety.
These compounds seem to play a negative role in growth and colony differentiation
in S. argillaceus, and some of them show weak antibiotic activity. A pathway for the
biosynthesis of argimycins P is proposed, based on the analysis of proposed enzyme
functions and on the structure of compounds encoded by the arp cluster.
Keywords: cryptic, type I polyketide synthase, pyridine, piperidine, thioester reductase, growth, alkaloid,
Streptomyces
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INTRODUCTION
Natural products have been a productive source of bioactive
compounds and drugs. By the mid-1990s, >50% of all new drugs
were either natural products or analogs (Cragg et al., 1997).
This frequency has decreased since then, due to the increased
efforts in synthetic small molecules, while the isolation and
characterization of new natural products from crude extracts
remains perceived as time-consuming and labor-intensive.
However, natural products and their analogs still account for
>40% of small molecule drugs under development (Newman
and Cragg, 2016). The importance of drug development based
on natural products and their analogs is, in part, associated with
their structural diversity, which facilitates opening up unexplored
chemical spaces (Bauer et al., 2010). The growing appreciation of
functional assays and phenotypic screens may further contribute
to a revival of interest in natural products for drug discovery
(Harvey et al., 2015).
Streptomycetes are Gram-positive bacteria with high GC
DNA content that are mainly found in terrestrial and aquatic
environments, and show a complex development cycle, involving
formation of substrate and aerial mycelium, and spores (Flärdh
and Buttner, 2009; Barka et al., 2016). Moreover, they are
one of the most important sources of microbial bioactive
compounds. These compounds are secondary metabolites
that show, among others, antibiotic, antifungal, antiparasitic,
immunosuppressive or herbicide activities. In addition, some
of them also play a role in colony development in these
microorganisms (Barka et al., 2016). Most bioactive compounds
belong to the polyketide, peptide, hybrid polyketide-peptide
and terpene groups. Polyketides (PK) are synthesized by
macroenzyme complexes called polyketide synthases (PKS)
through the condensation of small acyl-CoA units. Three
different types of PKS have been described so far. Type I or
modular PKS are typically organized into modules, each one
responsible for a single elongation cycle. Each module contains
a β-ketoacyl synthase (KS), an acyltransferase (AT) and an acyl
carrier protein (ACP) domain. AT domains select the appropriate
acyl-CoA unit that will be used in the corresponding extension
cycle; KS domains are responsible for the decarboxylative
Claisen condensations of acyl-CoA units; ACPs are non-catalytic
domains that tether the growing PK chain and building block
on its phosphopantetheine arm. After every condensation step,
the resulting β-keto group of the biosynthesis intermediate
could be modified before the next elongation step by functional
domains optionally present in the corresponding module:
ketoreductase (KR), dehydratase (DH), and enoyl reductase
(ER). KRs stereospecifically reduce the carbonyl group of the
β-ketoacyl-ACP intermediates leading to the formation of a
β-hydroxyl group; DH domains catalyze reversible dehydration
events to yield double bond formation between the α- and
β-carbons in the polyketide chain; ER domains catalyze the
reduction of double bonds to form fully reduced methylene in
the carbon chain (Hertweck, 2009; Weissman, 2015).
Novel compounds are still needed to address uncovered
medical needs, like infectious diseases, or cancer. Natural
products possess desirable structural and chemical properties
that make suitable as potent drugs, but steep technological
challenges associated with screening and manufacturing of these
molecules has stifled the discovery and development of natural
products. The recent development of genomics, metagenomics
and high-throughput screening has increased exponentially the
volume of useful genetic sequence information that can be
employed for natural products discovery. Additionally, a new
manufacturing paradigm employing metabolic engineering and
synthetic biology as its engine has greatly accelerated the path of
development for microbial natural product drugs (Rutledge and
Challis, 2015; Katz and Baltz, 2016; Pawar et al., 2016). Genome
mining consists of searching a genome for genes that encode
enzymes involved in a particular process. In recent years, genome
mining has been applied to streptomycetes and has become a
new and quick approach to identify previously unknown gene
clusters (Olano et al., 2014; Rutledge and Challis, 2015; Ochi,
2016). In most cases these clusters are silent or lowly expressed
under laboratory conditions. Therefore, several strategies have
been developed to awake and/or increase their expression, and
to identify the compounds encoded by these gene clusters, which
involve both the use of genetic engineering approaches and the
use of different media and culture conditions (Olano et al., 2014;
Rutledge and Challis, 2015; Ochi, 2016).
In this paper we report the genome mining of Streptomyces
argillaceus ATCC 12956, a producer of the known antitumoral
drug mithramycin, and the use of this approach to uncover
cryptic pathways, lowly or not expressed by the wild type strain.
One of these pathways lowly expressed under standard laboratory
conditions, has been overexpressed and the products isolated and
characterized chemically and biologically, namely the argimycin
P family of compounds.
MATERIALS AND METHODS
Bacterial Strains, Culture Conditions,
Plasmids and DNA Manipulations
Streptomyces argillaceus ATCC 12956, and S. argillaceus GIH,
S. argillaceus AFTA and S. argillaceus AFTA-GIH (Zabala
et al., 2013) were used as source of DNA and for gene
replacement and expression experiments, and/or production
of argimycins P. For sporulation the strains were grown
for 7 days at 30◦C on agar plates containing medium A
(Fernández et al., 1998). Streptomyces sp. NRRL S-1022 was
used to test argimycins P production. SM10 and SM17 media
were used for argimycins P production by S. argillaceus and
Streptomyces S-1022, respectively. When required, antibiotics
were added to media at the following final concentrations:
ampicillin (100 µg/mL), kanamycin (50 µg/mL), nalidixic
acid (25 µg/mL), apramycin (25 µg/mL), and thiostrepton
(50 µg/mL). A pKC505-based cosmid library of S. argillaceus
genome DNA was used to identify cosmids containing arp genes
(Lombó et al., 1996). Escherichia coli DH10B (Invitrogen) and
E. coli ET12567/pUB307 (Kieser et al., 2000) were used as cloning
hosts for plasmid propagation and for conjugation experiments,
respectively. Antibiotic activity of argimycins P was assayed
against Micrococcus luteus, Escherichia coli and Saccharomyces
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cerevisiae, as described Vilches et al. (1990). Plasmids pCR-
Blunt (Invitrogen) and pUO9090 (M. C. Martín, unpublished
results), were used for subcloning. Plasmids pHZ1358 (Sun
et al., 2002) and pBSKTT (this work) were used for generating
mutants by gene replacement and gene disruption. pEM4ATC (C.
Cano-Prieto, unpublished results) and pIAGO (Aguirrezabalaga
et al., 2000) were used for gene expression in S. argillaceus.
pBSKTT was constructed by cloning a PstI fragment containing
the oriT from pEM4T (Menéndez et al., 2006), into the PstI
site of pBSKT (Lombó et al., 1999). DNA manipulations,
transformations and intergeneric conjugations were performed
according to standard procedures for E. coli (Sambrook and
Russell, 2001) and for Streptomyces (Kieser et al., 2000). Herculase
(Stratagene) and 2.5% dimethyl-sulfoxide (DMSO) were used
for PCR amplifications. Purified amplicons were sequenced and
compared to others in databases.
Sequencing and Analysis of DNA
Streptomyces argillaceus genome DNA sequence was obtained
by Life Sequencing (Valencia, Spain; pyrosequencing 454 Life
Science-Roche platform). Paired end sequences were de novo
assembled using the Newbler assembler v. 2.8 (Margulies
et al., 2005). Sequence of cluster 18 was completed using
PCR fragments (Sanger et al., 1977) (DNA sequencing service;
University of Oviedo). Annotation was performed using
PGAAP (Prokaryotic Genomes Automatic Annotation Pipeline)
(Angiuoli et al., 2008). Database searching and sequence analysis
were carried out using antiSMASH (Antibiotic and Secondary
Metabolite Analysis Shell) (Blin et al., 2013; Medema et al., 2015;
Weber et al., 2015), and BLAST (Altschul et al., 1997). Analysis
of domains in PKS and NRPS were carried out using ASMPKS
(Tae et al., 2007) and NRPS predictor (Rausch et al., 2005). Search
for transmembrane domains was carried out using the TMHMM
v.2.0 (Krogh et al., 2001).
Plasmid Constructs for Gene Expression
and Generating Mutants
Several plasmids were generated as described in Supplementary
Material, either to express arp genes or to generate mutants
in S. argillaceus (Table 1). Mutants were generated by either
disrupting the target gene by inserting a plasmid, or by replacing
a DNA region by an apramycin resistance cassette that was
inserted in the same direction of transcription. These plasmids
were independently introduced by conjugation into S. argillaceus,
and transconjugants were selected either with thiostrepton
(pBSKTT-based plasmids) or with apramycin (pHZ1358-based
plasmids). In the last case, apramycin-resistance, thiostrepton-
sensitive colonies were selected. Mutants were confirmed by PCR
amplification using specific oligonucleotides (Supplementary
Table S1), and sequencing the PCR products.
UPLC Analysis and Purification of
Argimycins P
Culture samples (1 ml) were extracted with 1 volume of
n-butanol. Organic extracts were dried under vacuum, and
residues were dissolved in a small volume of DMSO: methanol
(50:50). Analysis of argimycins P production was performed by
reversed-phase chromatography on Acquity UPLC equipment
with a BEH C18 column (1.7µm, 2.1× 100 mm; Waters, Milford,
MA, USA) with acetonitrile and 0.1% trifluoroacetic acid (TFA)
in water as eluent. Samples were eluted with 10% acetonitrile for
1 min, followed by a linear gradient from 10 to 61.4% acetonitrile
over 4 min at a flow rate of 0.5 ml/min and a column temperature
of 30◦C. Detection and spectral characterization of peaks were
carried out with a photodiode array detector and Empower
software (Waters). Chromatograms were extracted at 400, 272,
and 230 nm.
For purification purposes, S. argillaceus MARPRII was grown
by a two-step culture method, as previously described Fernández
et al. (1998). In the production step, 40 250-milliliter Erlenmeyer
flasks, each containing medium (50 mL), were incubated for
3 days. The cultures were centrifuged and filtered, and applied
to a solid-phase extraction cartridge (Sep-Pak Vac C18, 10 g,
Waters). The retained material was eluted with a mixture of
methanol and 0.1% TFA in water. A linear gradient from 0 to
100% methanol in 55 min, at 5 ml/min, was used. Fractions were
taken every 5 min, and analyzed by UPLC. Fractions containing
the desired compounds were evaporated in vacuo, and dissolved
in a small volume of a mixture of DMSO and methanol (50:50).
Products were purified by preparative HPLC using a SunFire
C18 column (10 µm, 10 × 150 mm, Waters). Compounds were
chromatographed with mixtures of acetonitrile and 0.1% TFA in
water, in isocratic conditions optimized for each compound, at
5 ml/min.
Structural Characterization of
Compounds
LC/MS (liquid chromatography mass spectrometry) analyses
were carried out on an Agilent 1200 Rapid Resolution HPLC
TABLE 1 | Mutant and recombinant S. argillaceus strains generated in this
work.
Strains Plasmid used Gene(s)∗
Mutant strains
MARPN pHZMutAT arpN
MARPPIII pBSKTT1701 arpPIII
MARPRI pHZMutSARP arpRI
MARPRII pHZMutTetR arpRII
MORF3 pHZMutorf3 orf3
MORF4 pHZMutorf17 orf4
MORF9 pHZMutNAcTr orf9
DARPO-HII pHZDel59b arpO, arpDHI, arpDHII, arpN,
arpK, arpHI, arpHII
DORF5-7 pHZDel1820 orf5, orf6, orf7
DORF11-16 pHZDel13 orf11, orf12, orf13, orf14,
orf15, orf16
DORF19-21 pHZDel2 orf19, orf20, orf21
Recombinant strains
MARPPIII (pEM4ATCPKS) pEM4ATCPKS arpPIII, arpT
DARPO-HII (pIAGOorf8) pIAGOorf8bis arpN
∗Genes mutated or expressed.
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system equipped with a SB-C8 column (2.1 × 30 mm, Zorbax)
and coupled to a Bruker maXis mass spectrometer. Samples
were subjected to LC/ESI-TOF analysis in order to determine
their molecular formula. For the Nuclear Magnetic Resonance
(NMR) analysis samples were dissolved in deuterated methanol
(CD3OD) and transferred to a 1.7 mm tube. Acquisitions were
carried out on a Bruker AVANCE III 500 MHz spectrometer
equipped with a 1.7 mm TCI Microcryoprobe. All spectra were
recorded at 297 K. Structural elucidation of compounds was
carried out by analysis of a combination of 1D (1H and 13C),
and 2D (1H-1H COSY, TOCSY, HSQC and HMBC) NMR
experiments.
Determination of Stereochemistry of
Argimycins PI and PII
A solution containing argimycins PI/PII was subjected to a
desulfurization/reduction reaction using the method reported
by Martin et al. (2004) with some modifications: a solution of
argimycins PI and PII (1.0 mg) and nickel chloride (2.0 mg) in
2.0 mL of MeOH/H2O was added to a screwcap flask containing
NaBH4 (2.0 mg) with immediate resealing of the reaction vial.
A black precipitate, namely Ni2B, was immediately formed
and the mixture stirred for 1h at 50◦C. After centrifugation,
the supernatant containing the released N-acetylalanine was
recovered, evaporated to dryness and subjected to the Marfey’s
analysis (Marfey, 1984): 0.4 mg of the reaction product were
suspended in 1.0 mL of 12 N HCl and heated at 110◦C for 2 h. The
crude hydrolysate was evaporated to dryness under a nitrogen
stream, and the residue was dissolved in 100 µL of miliQ H2O.
A 1% (w/v) solution (100 µL) of L-FDVA [N-(2,4-dinitro-5-
fluorophenyl)-valinamide] in acetone was added. After addition
of 20 µL of 1 M NaHCO3 solution, the mixture was incubated
at 40◦C for 60 min. The reaction was quenched by addition of
10µL of 1 N HCl, and the crude mixture was diluted with 700µL
of acetonitrile and analyzed by LC/MS on an Agilent 1100 single
quadrupole. Similarly, the standards of L- and D-alanine were
also separately derivatized L-FDVA, according to the method
mentioned above. Separations were carried out on an Agilent
Zorbax SB-C8 column (2.1 × 30 mm, 3.5 µm) maintained at
40◦C. A mixture of two solvents, A (10% acetronitrile, 90% water)
and B (90% acetonitrile, 10% water), both containing 1.3 mM
trifluoroacetic acid and 1.3 mM ammonium formiate, was used as
the mobile phase under a linear gradient elution mode (10-40% B
in 11 min, then 100% B) at a flow rate of 0.3 mL/min.
RESULTS
Genome Mining of Streptomyces
argillaceus ATCC 12956 Genome
Streptomyces argillaceus ATCC 12956 genomic DNA was
subjected to 454 sequencing, yielding 512,452 paired end
sequences with a mean of 340.62 nt (174.55 Mb total). De
novo assembly of these sequences resulted in 1538 contigs, 1330
of which were larger than 500 nucleotides. The N50 of the
contig assembly was around 10.5 Kb, being the largest around
68.1 Kb. Most of these contigs were ordered in 20 scaffolds:
the N50 of the scaffolding was 1.2 Mb and the largest scaffold
was 3.5 Mb. This combination of scaffolds and contigs resulted
in an estimated genome size of 10.7 Mb. Genome analysis led
to the annotation of 7638 coding sequences, 4 rRNAs and 66
tRNAs. Sequence analysis with antiSMASH (Blin et al., 2013;
Medema et al., 2015; Weber et al., 2015) predicted the existence
of 31 biosynthetic gene clusters (BGCs), including five for PKs,
two for non-ribosomal peptides (NRPs), three for hybrid PK-
NRPs, seven for ribosomally synthesized and post-translationally
modified peptides (RiPPs) and four for terpenes (Table 2).
Among PK clusters, there are two for type II PKS: cluster
6 corresponds to the already characterized mithramycin gene
cluster (Lombó et al., 2006); and cluster 8 most probably is
involved in the biosynthesis of a spore pigment. At the time of
analysis, no prediction was available for compounds encoded by
type I (clusters 18 and 23) and type III (cluster 3) PK clusters.
The PK-NRP cluster 27 was predicted to be involved in antimycin
biosynthesis, since it shows strong similarity to antimycin clusters
TABLE 2 | Secondary metabolite gene clusters identified in S. argillaceus
by genome mining.
Cluster Type Predicted product
1 Butyrolactone Unknown
2 Thiopeptide Lactazole-like
3 Type III PKS Unknown
4 Other Unknown
5 Other Unknown
6 Oligosaccharide-Type II PKS Mithramycin
7 Bacteriocin Unknown
8 Type II PKS Putative spore pigment
9 NRPS Unknown
10 Ectoine Hidroxyectoine
11 TransAT-PKS-NRPS Unknown
12 Melanin Melanin
13 Siderophore Desferrioxamine
14 NRPS Unknown
15 Terpene Albaflavenone
16 Lantipeptide Unknown
17 Siderophore Unknown
18 Type I PKS Argimycins P(a)
19 Bacteriocin Unknown
20 Butylolactone-terpene Gamma-butyrolactone/geosmine
21 Siderophore Unknown
22 Terpene Hopene
23 Type I PKS Unknown
24 Bacteriocin Unknown
25 Melanin Melanin
26 Terpene Isorenieratene
27 PKS-NRPS Antimycins
28 Lantipeptide-NRPS Unknown
29 Lantipeptide Unknown
30 Other Unknown
31 PKS-NRPS Unknown
(a)this work; PKS, polyketide synthase; NRPS, non-ribosomal peptide synthetase.
Frontiers in Microbiology | www.frontiersin.org 4 February 2017 | Volume 8 | Article 194
fmicb-08-00194 February 8, 2017 Time: 14:51 # 5
Ye et al. New Alkaloid Compounds by Genome Mining
FIGURE 1 | Genetic organization of cluster 18. Genes are shown to scale. Argimycins P biosynthesis genes (arp) are shown in gray. Other genes are shown in
white and are numbered. Triangles indicate those genes that have been inactivated. Bars indicated DNA regions that have been deleted. Black lines represent
overlapping cosmids isolated from this chromosomal DNA region.
that are highly conserved in other microorganisms (Seipke et al.,
2011), while no assumption could be done for the PK-NRP
clusters 11 and 31. Based on the strong similarities to other
terpene biosynthesis gene clusters, cluster 15 was predicted to
code for albaflavenone, described in S. coelicolor (Zhao et al.,
2008); cluster 20 contains homologous genes to sabRAS, involved
in gamma-butyrolactone biosynthesis in S. acidiscabies (Healy
et al., 2009), and a geosmine synthase homologous gene that
has been reported to be the only gene required for geosmine
biosynthesis (Cane et al., 2006); cluster 22 was similar to hopene
biosynthesis gene clusters (Ghimire et al., 2015); and cluster 26
would code the isorenieratene carotenoid (Takano et al., 2005).
Some other clusters showed similarity to already known clusters,
which has allowed predicting the corresponding biosynthesis
products. For example, cluster 2 might be involved in the
biosynthesis of a lactazole thiopeptide, similar to that described
in S. lactacystinaeus (Hayashi et al., 2014). Also, cluster 10 would
code for hydroxyectoine, described in other organisms such
as S. chrysomallus (Prabhu et al., 2004); and cluster 13 that
contains all genes required for the biosynthesis of siderophore
desferrioxamine, described in S. coelicolor (Barona-Gómez et al.,
2004). On the other hand, some of the clusters showed high
similarity to very well conserved clusters, the metabolic products
of which are not known. This is the case of cluster 9 (NRPs), and
clusters 17 and 21 (NRPS-independent siderophores).
Analysis of Cluster 18 and Identification
of Encoded Compounds
Among the 31 S. argillaceus identified clusters, cluster 18
was selected for further characterization. This cluster spanned
68.295 kb and contained 37 open reading frames (orf ), including
three coding for a type I PKS, seven for regulatory genes and
several for tailoring enzymes (Figure 1; Table 3). According to
Table 3, ArpPI to ArpPIII PKS show strongest homology to
the three PKS from the streptazone E biosynthesis gene cluster
(Ohno et al., 2015). Co-linearity of cluster 18 was confirmed
using PCR probes from different DNA regions of the cluster, to
identify overlapping cosmids from an S. argillaceus gene library,
followed by sequencing the ends of DNA inserts in these cosmids
(Figure 1). Sequence of this cluster has been deposited at the
European Nucleotide Archive (EBI-ENA) under the accession
number LT615255, and at MIBIG under the accession number
BGC0001433.
To identify the biosynthesis product(s) of this cryptic gene
cluster, two approaches were followed in parallel: (i) Generation
of a mutant in a PKS gene. To completely block the biosynthesis
pathway directed by cluster 18, the PKS gene arpPIII was
disrupted by inserting pBSKTT1701 into this gene, generating
mutant MARPPIII (Table 1; Supplementary Figure S1); (ii)
Inactivation of the putative tetR-like transcriptional repressor
gene arpRII. Cluster 18 contains seven putative transcriptional
regulatory genes: two coding for SARP-like activators (orf1
and arpRI), two for Xre-like regulators (orf2 and orf22), one
for a FMN binding repressor (orf7), and one for a tetR-like
repressor (arpRII). This last one (arpRII) was located two
orfs downstream of PKS genes. Since TetR regulators usually
behave as transcriptional repressors (Ramos et al., 2005), arpRII
was inactivated to increase production of compounds encoded
by the cluster, which will facilitate their identification. Using
pHZMutTetR, most of arpRII was replaced by an apramycin
resistance cassette generating mutant MARPRII (Table 1;
Supplementary Figure S2).
Mutants MARPPIII and MARPRII (and the wild type strain
as control) were cultivated in R5A medium to compare the
metabolite profiles of these strains. Culture samples were
harvested along growth and extracted with different solvents
(ethyl acetate; ethyl acetate and 0.1% formic acid; n-butanol; or
chloroform). Extracts were run by UPLC and chromatograms
were obtained at 400, 272, and 230 nm, and analyzed by
identifying peaks that disappeared in MARPPIII and increased
in MARPRII, in relation to the wild type strain. Chromatograms
of n-butanol extracts showed differential peaks between strains
Frontiers in Microbiology | www.frontiersin.org 5 February 2017 | Volume 8 | Article 194
fmicb-08-00194 February 8, 2017 Time: 14:51 # 6
Ye et al. New Alkaloid Compounds by Genome Mining
(data not shown). Since the corresponding compounds were
mostly produced in very low amounts, a media screening was
conducted to increase their production levels. SM10 medium was
selected as the best medium and was used thereafter. Figure 2
shows UPLC analysis of n-butanol extracts of MARPPIII and
MARPRII cultivated in SM10, in comparison to those from the
wild type strain. As it can be observed, inactivation of arpPIII
(S. argillaceus MARPPIII) led to the disappearance of peaks
present in the wild type strain: at 400 nm (Figure 2A, peaks I,
II and N), 272 nm (Figure 2B, peaks IV, V and VI) and 230 nm
(Figure 2C, peak IX). HPLC-MS analysis of the corresponding
compounds revealed m/z values in positive mode of 331 for peaks
I and II; 176 for peaks N and VI; 208 for peak IV; 192 for
peak V; and 178 for peak IX. Detection of these compounds was
recovered by expressing arpPIII (plus arpT) under the control
of the erythromycin resistance promoter (pEM4ATCPKS), into
MARPPIII (Figures 2A–C). On the other hand, inactivation
of putative repressor gene arpRII (mutant MARPRII) led to
a clear increase of production of most of these compounds
(Figures 2A–C). From all these results it was deduced that
compounds from those peaks were encoded by cluster 18. In
addition, analysis of the three subunits of type I PKS encoded by
cluster 18 suggested that the PK chain synthesized by this enzyme
would result from the condensation of six malonyl-CoA units.
Consequently, strains with higher intracellular concentration
of malonyl-CoA should produce higher amounts of these
compounds. Therefore, S. argillaceus GIH (overexpressing the
acetyl-CoA carboxylase ovmGIH genes), S. argillaceus AFTA (a
mutant in the acyl-CoA:diacylglycerol acyltransferase aftAa gene)
and S. argillaceus AFTA-GIH (S. argillaceus AFTA overexpressing
TABLE 3 | Functions of gene products from cluster 18.
Gene aa Proposed function Similar protein (acc. number) Identical aa (%)
Orf1 360 SARP-like transcriptional regulator WP_037724676.1 80
Orf2 773 Xre-like transcriptional regulator WP_061914503.1 80
Orf3 254 Hypothetical protein WP_031129425.1 81
ArpRI 828 SARP-like transcriptional regulator WP_051790319.1 81
ArpO 483 Dehydrogenase WP_030346790.1 87
ArpDHI 392 Dehydrogenase/hydroxylase WP_030346791.1 96
ArpDHII 293 Imine reductase WP_030346792.1 96
ArpN 534 Aminotransferase WP_030346793.1 90
ArpK 182 Flavin reductase WP_037814843.1 93
ArpHI 137 Cyclase WP_030346795.1 95
ArpHII 136 Cyclase WP_030346796.1 92
ArpPI 4625 Type I Polyketide Synthase BAT51065.1 75
ArpPII 3575 Type I Polyketide Synthase BAT51066.1 69
ArpPIII 2203 Type I Polyketide Synthase BAT51067.1 73
ArpT 257 Type II thioesterase WP_030348965.1 86
ArpX 177 Unknown WP_031487542.1 88
ArpRII 210 TetR-like transcriptional repressor WP_019065342.1 79
Orf4 215 Reductase WP_030993716.1 84
Orf5 126 Hypothetical protein WP_030579546.1 63
Orf6 381 Oxidase WP_024490800.1 75
Orf7 212 Putative transcriptional repressor WP_063624787.1 63
Orf8 381 Monooxygenase WP_051386635.1 63
Orf9 167 N-acetyltransferase WP_024490799.1 49
Orf10 406 Cytochrome P450 WP_024490798.1 82
Orf11 559 AMP-dependent synthetase and ligase WP_037777637.1 80
Orf12 285 Hypothetical protein WP_024490796.1 90
Orf13 170 Thioesterase WP_024490795.1 84
Orf14 96 Acyl carrier protein WP_052488578.1 65
Orf15 307 Methyltransferase WP_037777640.1 82
Orf16 291 Thioesterase WP_024490792.1 87
Orf17 234 Phosphopantetheinyl transferase WP_024490791.1 54
Orf18 208 Pyrophosphorylase WP_028437185.1 48
Orf19 137 Dehydratase WP_051387014.1 74
Orf20 134 Thioesterase WP_051387012.1 80
Orf21 333 3-oxoacyl-ACP synthase WP_040020314.1 75
Orf22 161 Xre-like transcriptional regulator WP_024495143.1 77
Orf23 163 LuxR-like transcriptional regulator WP_061444915.1 63
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FIGURE 2 | UPLC chromatograms of S. argillaceus wild type and
mutant strains in arp genes. Butanol extracts of S. argillaceus wild type
strain (WT), S. argillaceus MARPPIII, S. argillaceus MARPRII, and
S. argillaceus MARPPIII (pEM4ATCPKS). Chromatograms are shown at
400 nm (A), 272 nm (B) and 230 nm (C). Peaks corresponding to the different
argimycins P are indicated as follows: argimycins PI and PII (I and II);
nigrifactin (N); argimycin PIV (IV); argimycin PV (V); argimycin PVI (VI); and
argimycin PIX (IX).
the acetyl-CoA carboxylase genes), which accumulate higher
concentrations of malonyl-CoA (Zabala et al., 2013), were tested
for production of compounds corresponding to peaks I and II
(331 mass). As expected, higher production of these compounds
was obtained with all strains, being the highest increases with
S. argillaceus AFTA-GIH (Table 4).
Purification, Structural Elucidation and
Bioactivity of Compounds Encoded by
Cluster 18
Compounds from those peaks mentioned above were purified
by preparative HPLC. Although peaks I and II were purified
independently, they both correspond to a mixture of two main
compounds that were present in different proportions. The major
compound in peak I was named argimycin PI, and that in peak
II argimycin PII. Moreover, there was a gradual interconversion
of argimycin PII into argimycin PI and vice versa along time,
till reach an equilibrium in which both compounds were present
in the same proportion in both samples. Yields obtained for the
different compounds were as follows: 3.5 mg (peak I); 3.2 mg
(peak II); 3.9 mg (peak N, nigrifactin/named argimycin PIII);
8.8 mg (peak IV, named argimycin PIV); 1.9 mg (peak V,
named argimycin PV); 0.9 mg (peak VI, named argimycin PVI);
and 1 mg (peak IX, named argimycin PIX). The structure of
these compounds, subsequently named argimycins PI-IX, were
elucidated by NMR and MS analyses (Figure 3).
Argimycin PI shows a molecular formula C17H18N2O3S on
the basis of the molecular ion m/z 331.1109 obtained by ESI-
TOF ([M+ H]+, calcd. for C17H19N2O3S+, 331.1116), that
additionally displayed the typical isotope pattern for compounds
that contain a sulfur atom. Sulfur has an isotopic distribution
showing three isotopes, 32S, 33S and 34S, with a ratio 100/0.8/4.5.
Therefore, compounds containing a sulfur atom show in their
MS spectra an M+2 ion with an increased intensity with respect
to non-sulfur containing molecules. Supplementary Figure S3
shows the experimental and simulated (for a molecular formula
of C17H19N2O3S) HRMS spectra of argimycin PI, indicating
agreement with the presence of a sulfur atom in the molecule
(not the case if the simulated formula was C17H19N2O4). The
same molecular formula was determined for argimycin PII,
based on the observed molecular ion m/z 331.1112 and the
identical isotope pattern as argimycin PI. MS/MS experiments
in ESI+ mode revealed, for both molecules, that the parent ion
(C17H18N2S + H+) generated a C12H12NS+ fragment, and in
turn, loss of SH2 provided the C12H10N+ ion. Fragmentation
under ESI- conditions provided ion [M-H]− (m/z 329) as
base peak, suggesting the presence of an acidic proton. NMR
analysis (Table 5) showed 7 aromatic/olefinic protons, one
methylene and one methine, both of them bound to heteroatom
and two single methyl groups. Based on this data, together
with the coupling constants from 1H-NMR and information
from bidimensional COSY, HSQC, 13C-HMBC 15N-HMBC
and NOESY, connectivity and stereochemistry of argimycin
PI and PII was determined (Supplementary Figures S4–S11).
Supplementary Figure S12 shows the signal assignments and the
correlations observed by NOESY. For argimycin PII the NOESY
experiment, which showed interaction between H8 and H4, while
H9 interacts with H6 and Me-11, proved key to determine the
correct stereochemistry of the double bonds (Supplementary
Figure S13). The connectivity of the two isomeric argimycins
PI and PII explains the results of the MS experiments. Under
ESI- mode, both molecules ionize as [M-H]- (m/z 329), in
TABLE 4 | Productions of peaks I and II in S. argillaceus strains containing
higher intracellular concentration of malonyl-CoA.
Strain Peak I∗ Peak II∗
WT 43188 ± 1871 55614 ± 2979
GIH 55395 ± 11477 63914 ± 9257
AFTA 85358 ± 4543 102456 ± 5311
AFTA-GIH 151616 ± 18711 171609 ± 7102
∗Area of peaks, in arbitrary units.
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FIGURE 3 | Chemical structures of argimycins P (relative configuration shown for argimycins PI, PII, PIV, PV, and PVI).
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agreement with the carboxylic acid function. Also, under ESI-,
a fragment C12H10NS− (m/z 200) is observed, which can be
explained by a decarboxylation shown in Supplementary Figure
S14. The stereochemistry of the N-acetylcysteine contained
in these compounds was unambiguously established as ‘L’
by means of a previous desulfurization/reduction reaction to
release N-acetylalanine, and further hydrolysis and analysis of
the released amino acid derivatized with L-FDVA. Under the
reported conditions, the retention times (min) for the derivatized
alanine standards were 4.79 (L-Ala) and 6.87 (D-Ala), being
the retention time for the observed peak in the HPLC trace of
the L-FDVA derivatized hydrolysis product of argimycins PI/PII
4.78 min, coincident with the retention time for L-Ala-L-FDVA
(see Supplementary Figure S15).
Table 6 shows the NMR signal assignments for argimycin
PIV, argimycin PV and argimycin PVI. Argimycin PV possesses
a molecular formula of C12H17NO, according to the base
peak m/z 192.1383 by ESI-TOF ([M+ H]+, calcd. for
C12H18NO+, 192.1388). The 1H-NMR spectrum showed five
olefinic protons and a methyl group signal, which was split into a
doublet (Supplementary Figure S16). Comparative analyses using
databases [Dictionary of Natural Products (DNP) NMR features]
with the molecular formula and the structural characteristics
mentioned, failed to dereplicate any possible candidate, hinting
to the novelty of its structure. Together with bidimensional NMR
and 13C-NMR spectra, the assignment provided in Table 6 was
established (positions numerated as in argimycins PI and PII).
Double bond relative stereochemistry for the ring fusion was
TABLE 5 | NMR data for argimycins PI-PII (1H, 500 MHz; 13C, 150 MHz, in
CD3OD)
Argimycin PI Argimycin PII
Carbon δH (mult, J, Hz) δC (ppm) δH (mult, J, Hz)
2 8.30 (d, 5.2) 143.6 8.30 (d, 5.2)
3 7.27 (dd, 7.7, 5.2) 119.2 7.24 (dd, 7.7, 5.2)
4 8.25 (d, 7.7) 127.9 8.12 (d, 7.7)
4a – 131.9 –
5 – n.d. –
6 7.67 (d, 5.6) 130.9 7.43 (d, 5.6)
7 7.00 (d, 5.6) 127.4 6.98 (d, 5.6)
7a – 159.1 –
8 7.69 (d, 11.8) 128.5 7.80 (d, 11.8)
9 6.96 (d, 11.8) 117.3 7.03 (d, 11.8)
10 – 148.2 –
11 2.33 (br s) 3H 17.6 2.38 (br s) 3H
12 3.62 (dd, 13.0, 4.6)
3.27 (dd, 13.0, 7.7)
32.4 3.49 (dd, 13.0, 4.6)
3.23 (dd, 13.0, 7.7)
13 4.74 (dd, 7.7, 4.7) 52.1 4.61 (dd, 7.7, 4.7)
14 – 172.3 –
16 – 171.7 –
17 2.01 (s) 3H 21.0 1.99 (s) 3H
Nitrogen δN (ppm)
1 259.1
15 121.9
established as cis (between the OH in 4a and the H in 7a) by
comparison with the chemical shifts and NOESY correlation
profile observed for argimycin PVI, whose stereochemistry was
unambiguously determined (see below).
Argimycin PVI possesses a molecular formula of C12H17N,
according to the base peak m/z 176.1433 by ESI-TOF ([M+
H]+, calcd. for C12H18N+, 176.1439). UV/vis spectrum shows
a similar profile, including the maximum at 272 nm, as in
argimycin PV. Comparison of the 1H-NMR spectra for argimycin
PV and argimycin PVI (Supplementary Figure S16) indicates
that both molecules are structurally related, the difference
in molecular formula suggests that argimycin PVI is the
dehydroxy analog of argimycin PV. Dereplication based on
molecular formula and NMR signals (DNP NMR features)
failed to identify any previously described product, confirming
the novelty of the structure. Bidimensional NMR spectra
(Supplementary Figure S17) were acquired to elucidate the
structure, assigning the signals unambiguously (Table 6). Double
bond stereochemistry was established based on the coupling
constants (identical profile as argimycin PV). NOESY spectrum
showed a correlation between H-4a and H-7a, confirming the
fused ring cis stereochemistry.
Argimycin PIV possesses a molecular formula of C12H17NO2,
according to the base peak m/z 208.1334 by ESI-TOF ([M+
H]+, calcd. for C12H18NO2+, 208.1338). UV/vis spectrum
shows a similar profile, including the maximum at 272 nm,
as in argimycin PV and argimycin PIV. Comparison of the
1H-NMR spectra for argimycin PVI in CD3OD and DMSO-
d6 showed that the former provides better signal resolution
(Supplementary Figure S18), and CD3OD was selected for
elucidation. This also facilitated comparison with argimycin PV
and argimycin PVI (Supplementary Figure S19), which indicates
that all three molecules are structurally related, the difference in
molecular formula suggests that argimycin PIV is a hydroxylated
analog of argimycin PV. As before, dereplication based on
molecular formula and NMR signals (DNP NMR features)
failed to identify any previously described product, confirming
the novelty of the structure. Bidimensional NMR spectra
(Supplementary Figure S20) were acquired to elucidate the
structure, assigning the signals unambiguously (Table 6). Double
bond stereochemistry was established based on the coupling
constants (identical profile as argimycin PV). NOESY spectrum
showed a correlation between H-4a and H-7a, confirming the
fused ring cis stereochemistry. Relative stereochemistry in C4
was established by the analysis of the coupling constant J at
H4 (dd, 6.6Hz, 3.0Hz). 3D modeling (hydroxyls in relative cis
position) shows dihedral angles (H4-H3a) = −170◦ and (H4-
H3b) = −55◦, compatible with the observed J values. On the
other hand, the modeling of the epimer at H4 shows dihedral
angles (H4-H3a) = −59◦ and (H4-H3b) = +59◦, incompatible
with the observed J values (Supplementary Figure S21).
Argimycin PIII (nigrifactin) possesses a molecular formula of
C12H17N, according to the base peak m/z 176.1438 by ESI-TOF
([M+H]+, calcd. for C12H18N+, 176.1439). UV/vis spectrum
shows a different profile, including a maximum at 350 nm.
Comparison of the 1H-NMR spectra for argimycin PIII in
CD3OD and DMSO-d6 showed that the later provides better
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TABLE 6 | NMR data for argimycins PIV-PVI (1H, 500 MHz; 13C, 150 MHz, in CD3OD).
Argimycin PIV Argimycin PV Argimycin PVI
Carbon δH (mult, J, Hz) δC (ppm) δH (mult, J, Hz) δC (ppm) δH (mult, J, Hz) δC (ppm)
2 3.27 (app quintet, ca. 6.3)
3.02 (app quintet, ca. 6.3)
35.5 3.18 (app quintet, ca. 6.3)
3.07 (app quintet, ca. 6.3)
39.1 3.13 (m)
3.00 (m)
40.3
3 1.97 (m) 1.72 (m) 23.3 1.95 (m) 1.68 (m) 16.4 1.78 (m) 1.69 (m) 17.6
4 3.89 (dd, 6.6, 3.0) 68.9 1.89 (m) 30.9 1.99 (m) 21.3
4a – 77.4 – 76.3 3.02 (m) 39.1
5 – 142.4 – 144.8 – 140.5
6 7.06 (br d, 6.0) 135.5 7.02 (br d, 6.0) 134.5 7.17 (br d, 5.8) 137.2
7 6.02 (br d, 6.0) 126.6 6.00 (br d, 6.0) 126.7 6.15 (br dt, 5.9) 129.3
7a 4.36 (br s) 67.0 4.13 (br s) 66.9 4.25 (dd, 6.5, 2.3) 59.4
8 6.15 (d, 11.2) 125.2 6.10 (d, 11.2) 123.0 6.04 (d, 11.1) 123.4
9 6.49 (ddq, 14, 11.2, 1.5) 127.5 6.47 (ddq, 14.0, 11.2, 1.6) 127.4 6.52 (ddq, 14, 11.1, 1.6) 127.6
10 5.91 (dq, 14, 6.7) 132.1 5.88 (dq, 14.0, 6.8) 131.5 5.83 (dq, 14, 6.8) 130.2
11 1.85 (br d, 6.7) 17.1 1.84 (dd, 6.9, 1) 17.1 1.83 (brd, 6.9) 16.9
signal resolution (Supplementary Figure S22), but CD3OD was
selected for elucidation in order to facilitate comparison with
argimycin PIV, argimycin PV and argimycin PVI (Supplementary
Figure S23). This comparison clearly shows that argimycin PIII
is not structurally similar to the other three fused bicyclic
argimycins P. In this case, dereplication based on molecular
formula and NMR signals (DNP NMR features) provided a
candidate, the previously described alkaloid nigrifactin (UV/vis
max at 350 nm), which indeed is biosynthetically related to the
argimycins PIV-PVI. Further analysis including bidimensional
NMR spectra permitted the elucidation and signal assignment
described in Table 7. All-trans stereochemistry of the double
bonds was confirmed by analysis of coupling constants.
Argimycin PIX possesses a molecular formula of C12H21N,
according to the base peak m/z [M+H]+ observed at 180.1753
(calcd. for C12H22N+ = 180.1747). Searching this molecular
formula in the DNP retrieved just one hit, 2-octylpyrrole which
was not compatible with the NMR spectrum observed for
argimycin PIX. The molecular formula contains two degrees
of unsaturation less than nigrifactin (C12H17N), which agrees
with a structure similar to that of nigrifactin with two double
bonds less, reducing the conjugation level in agreement with the
observed UV maximum at 225 nm (compared to the 352 nm
for nigrifactin). The 1H-NMR (Supplementary Figure S24) and
HSQC (Supplementary Figure S25) spectra showed four olefinic
methine groups, one aliphatic N-bound methine, one methyl
doublet very similar to that of nigrifactin and six aliphatic
methylene groups (one of them bound to N). All these features
were in agreement with the preliminary hypothesis of a partially
reduced nigrifactin structure. Further analysis of the whole set
of 2D NMR spectra (including COSY and HMBC) allowed
the elucidation of the compound structure. The configuration
of double bonds was established by analysis of the coupling
constants, permitting the elucidation and signal assignment
described in Table 7.
Cytotoxic activity of argimycins P was evaluated against a
panel of 59 tumor cell lines, using 10 µM concentrations.
None of them showed cytotoxic activity (data not shown). In
TABLE 7 | NMR data for argimycin PIII (nigrifactin) and argimycin PIX (1H, 500 MHz; 13C, 150 MHz, in CD3OD).
Argimycin PIII (nigrifactin) Argimycin PIX
Carbon δH (mult, J, Hz) δC (ppm) δH (mult, J, Hz) δC (ppm)
2 3.70 (m) 44.0 3.36 (br dt, 13.0) 3.00 (td, 13.0, 2.6) 44.4
3 1.94 (m) 19.5 1.85 (m) 1.65 (m) 22.1
4 1.91 (m) 16.4 1.90 (m) 1.56 (qt, 12.9, 2.8) 21.6
5 3.02 (m) 24.4 2.05 (br dt, 14.0) 1.40 (br dd, 13.0 2.9) 28.0
6 – 178.5 3.06 (m) 56.0
7 6.43 (d, 15) 121.3 1.72 (m) 1.66 (m) 33.1
8 7.58 (dd, 15, 11) 149.5 2.20 (m) 27.3
9 6.45 (dd, 13, 11) 127.7 5.52 (ddd, 14.0, 7.0) 128.4
10 6.91 (dd, 14,11) 146.6 6.08 (dd, ca 14.0, 12.0) 131.7
11 6.34 (dd, 14, 11) 131.3 6.04 (dd, ca 14.0, 12.0) 131.1
12 6.20 (m) 139.0 5.64 (dq, 14.0, 6.8) 127.3
13 1.90 (br d, 7.0) 17.5 1.73 (br, d, 6.8) 16.7
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FIGURE 4 | Morphology of S. argillaceus strains: argimycins P
producers (wild type, WT; MARPRII); non-producer mutants (MARPPIII;
DARPO-HII); and complemented mutant (MARPPIII + pEM4TCPKS).
antibiotic activity tests nigrifactin (argimycin PIII), argimycins
PI and PII, and argimycin PVI showed weak antibiotic
activity against Micrococcus luteus (data not shown). On the
other hand, production of argimycins P exerts some effect
on S. argillaceus development. Growth on agar plates of
argimycins P producer and non-producer strains revealed
that non-producer mutants S. argillaceus MARPPIII and
S. argillaceus DARPO-HII grow and sporulate better than
producer strains (wild type and the overproducer strain
S. argillaceus MARPRII). Moreover, after complementing S.
argillaceus MARPPIII (S. argillaceus MARPPIII-pEM4ATCPKS)
this phenotype was reversed (Figure 4). This suggests that
argimycins P play some role in colony development in
S. argillaceus.
Limits of arp Biosynthesis Gene Cluster
Since cluster 18 was shown to encode argimycins P, this cluster
was renamed as cluster arp. Limits of the arp cluster were
established by comparing genes (and their gene products) located
at each end of the cluster with others in data-bases, together with
inactivating single genes and/or deleting set of genes located at
both ends (Table 1, Figure 1; Supplementary Figures S26–S32),
followed by analysis of argimycins P production in mutant strains
(Supplementary Figure S33).
At the left end of the cluster, a gene coding for an
unknown protein (orf3) and several others coding for regulatory
proteins (orf1, orf2 and arpRI) were located. orf1 to orf3
were homologous to genes in other Streptomyces that were
not involved in the biosynthesis of secondary metabolites,
either showing the same (Streptomyces sp. NRRL WC-3719)
or slightly different genetic organization (as in Streptomyces
sp. 769, Streptomyces sp. MspMP-M5 and S. natalensis ATCC
27448). This suggested that these genes were not involved
in argimycins P biosynthesis. To confirm this, orf3 was
inactivated by gene replacement. Using pHZMutorf3, the wild
type copy of orf3 was replaced by an apramycin resistance
cassette, generating mutant MORF3. Analysis of cultures of
mutant MORF3 revealed that still produces argimycins P,
confirming that orf3 was not necessary for argimycin P
biosynthesis. To establish the left boundary of the cluster,
inactivation of arpRI was carried out. Using pHZMutSARP
mutant MARPRI was generated by gene replacement. No
argimycins P were detected in cultures of MARPRI, proving the
involvement of arpRI in argimycins P biosynthesis. Therefore,
the left boundary of arp cluster was established as arpRI
(Figure 1).
On the right end of the cluster there were genes coding
for enzymes and regulatory proteins that could be involved
in argimycins P biosynthesis. To establish the right end of
the arp cluster, deletion and inactivation of specific genes
were carried out in a sequential way, starting from the far
3′-end of the cluster. First, orf19 to orf21 were deleted and
replaced by an apramycin resistance cassette using pHZdel2.
Since the resultant mutant DORF19-21 still produced argimycins
P, orf11 to orf16 were deleted next. This DNA region
included orf11, which codes for a putative AMP-dependent
syntethase and ligase that could be involved in activating
the cysteine residue that is present in argimycins PI and
PII. Using pHZDel13 mutant DORF11-16 was generated and
still produced argimycins P, including argimycins PI and PII,
indicating that this region is not required for argimycins P
biosynthesis and specifically, that orf11 is not involved in
activating the cysteine residue for the biosynthesis of argimycin
PI and PII. orf9 codes for an N-acetyl-transferase that was
envisioned to be involved in transferring the acetyl group
to the cysteine residue in argimycins PI and PII. Therefore,
orf9 was inactivated next. Using plasmid pHZMutNAcTr,
mutant MORF9 was generated and still produced argimycins P,
including PI and PII. This indicated that the orf9 gene product
was not the acetyl-transferase involved in the biosynthesis
of these argimycins P. Deletion of orf5 to orf7 (includes a
transcriptional repressor and an oxidase) and inactivation of
orf4 (coding for a reductase) were carried out next. Using
plasmids pHZDel1820 and pHZMutorf17, mutants DORF5-7
and MORF4 were generated by gene replacement. UPLC analysis
of culture extracts from these mutants showed that in both
cases argimycins P were still produced. All these results and
the mentioned above with MARPRII mutant, indicated that orf4
to orf23 were not necessary for argimycins P biosynthesis, and
established the right end of the cluster at arpRII (Figure 1). In
addition, these results showed that neither orf9 nor orf11 were
required for the formation of NAC moiety of argimycins PI
and PII.
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FIGURE 5 | Proposed biosynthesis pathway for argimycins P.
Analysis of Argimycin P Biosynthesis
Gene Cluster and Proposed Biosynthesis
Pathway
The arp cluster spanned 45.282 kb and includes fourteen genes:
two coding for regulatory proteins (arpRI and arpRII), eleven for
structural proteins (arpPI, arpPII, arpPIII, arpT, arpN, arpDHI,
arpDHII, arpHI, arpHII, arpO, and arpK), and one for a
hypothetical protein (arpX) (Figure 1; Table 3).
The ArpP type I modular PKS would synthesize a 12-carbon
PK backbone (Figure 5). It is constituted by three subunits:
ArpPI containing the loading domain (LD) and extension
modules 1 (M1) and 2 (M2); ArpPII with the third and fourth
extension modules (M3 and M4); and ArpPIII with the fifth
extension module (M5) and a thioester reductase domain (TR)
(Figure 5). All five extension modules and the LD contain a
β-ketoacyl synthase (KS), an acyl carrier protein (ACP) and
acyltransferase (AT) domain. KS domains will be responsible
for the decarboxylative Claisen condensations of six acyl-CoA
units to form the PK chain. The KS domains from M1 to
M5 contain the catalytic triad CHH (Xu et al., 2013). In the
LD, Gln is replacing Cys within the conserved amino acid
region AQSSS, indicating that the starter unit in the polyketide
biosynthesis would be malonyl-CoA (Bisang et al., 1999). All
ArpP ACPs contain the conserved Ser residue to which the
phosphopantetheine arm is linked (Donadio and Katz, 1992).
The ArpP AT domains contain the conserved amino acid region
GHSxG around the catalytic Ser residue, and are predicted to
accept malonyl-CoA as substrate since they carry signature motifs
associated with malonyl-CoA substrate specificity (Haydock
et al., 1995; Reeves et al., 2001; Yadav et al., 2003): presence
of a branched hydrophobic residue (Ile) beyond the catalytic
Ser; and a HAFH motif that includes the catalytic His. All five
extender modules in ArpP PKS contain a KR and a DH domain.
All ArpP KR domains contain the NADP(H)-binding motif and
the catalytic triad KSY (Reid et al., 2003). KRs are usually of
B1 type when they work together with processing enzymes like
DHs (Keatinge-Clay, 2007). Based on sequence fingerprints in
the LDD loop, catalytic region and Lid (Caffrey, 2003; Keatinge-
Clay, 2007), all ArpP KRs except KR4, could be classified into the
B1 type. Interestingly, in KR4 the conserved LDD motif is not
preserved: there is an Asn residue instead of the strictly conserved
Asp. Its absence could indicate that this KR is of A-type. However,
A-type KRs usually possess a Trp residue N-terminal to the
catalytic Tyr that is absent in KR4 (Caffrey, 2003; Keatinge-
Clay, 2007). This fact could indicate a malfunctioning of KR4
that could lead to a keto group at C8 in the nascent polyketide
chain (Figure 5). All ArpP modules contain a DH domain. DH1,
DH2 and DH3 show the four hallmark DH motifs, including
those around the catalytic residues His (HxxxGxxxxP) and Asp
(DxxxQ/H) (Keatinge-Clay, 2008). However, in DH4 and DH5
two of these motifs are lacking, which indicates that DH4 and
DH5 are inactive. Products of B-type KRs are dehydrated to
trans-double-bonds by the corresponding DH (Xu et al., 2013).
Accordingly, the polyene side chain of nigrifactin (argimycin
PIII), a putative early shunt product in argimycins P biosynthesis,
which would result from the activity of ArpP and ArpN (see
below), shows three trans-double-bonds. Typically, the release
of the full length polyketide chain is catalyzed by a thioesterase
domain (TE) located at the C-terminal of the last module.
However, in the ArpP PKS there is a TR domain instead that
would be responsible for the NAD(P)H-dependent reductive
release of the acyl thioester attached to the adjacent ACP domain
(Du and Lou, 2010) to yield the putative aldehyde product 1
(Figure 5). This TR domain shows the consensus motifs usually
found in this type of domains, both in NRPS and PKS (Konz and
Marahiel, 1999).
ArpT shows similarity to type II thioesterases such as
TamB (ADC79640.1; 47% identical amino acids) and TrdB
(ADY38534.1; 47% identical amino acids from tirandamycin
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FIGURE 6 | UPLC chromatograms at 350 nm of butanol extracts of
S. argillaceus DARPO-HII and S. argillaceus DARPO-HII (pIAGOorf8).
N, nigrifactin.
gene clusters in Streptomyces sp. 307-9 (Carlson et al., 2010)
and Streptomyces sp. SCSIO1666 (Mo et al., 2011), respectively;
and ScoT (NP_630685.1; 53% identical amino acids) from the
coelimycin P1 gene cluster in S. coelicolor M145 (Pawlik et al.,
2007; Gómez-Escribano et al., 2012). These proteins are editing
proteins that eliminate aberrant polyketide growing chains from
PKS, thus allowing its normal correct function (Heathcote et al.,
2001; Mo et al., 2011).
ArpN shows similarity to class III aminotransferases such
as CpkG (67% identical amino acids) that is involved in the
biosynthesis of coelimycin P1 in S. coelicolor (Pawlik et al.,
2007; Gómez-Escribano et al., 2012). These pyridoxal phosphate
(PLP)-dependent enzymes can catalyze the transfer of an amino
group from an amino donor to an aldehyde group. Accordingly,
ArpN is proposed to catalyze the amination of compound 1
(Figure 5). The resultant compound 2 could spontaneously
cyclize or could suffer other modifications before ring formation.
For example, in the biosynthesis of coelimycin P1 it has been
proposed that the transamination step is followed by several
epoxidations and oxidation before cyclization of the PK chain.
To understand the formation of the piperidine ring during
the biosynthesis of argimycins P, arpN was inactivated using
pHZMutAT (Table 1; Supplementary Figure S34). The resultant
mutant S. argillaceus MARPN neither produced any argimycin P
nor accumulated a new compound, which indicated that ArpN
was involved in the biosynthesis of argimycins P and suggested
its participation at an early step (Supplementary Figure S35).
Then, a second mutant was generated by deleting arpO to
arpHII genes, using pHZDel59b (Table 1; Supplementary Figure
S36). As expected, the resultant mutant S. argillaceus DARPO-
HII didn’t produce any argimycin P (Figure 6). When arpN
was expressed in this mutant, the resultant strain S. argillaceus
DARPO-HII pIAGOorf8 produced nigrifactin (Figure 6). These
results indicate that biosynthesis of nigrifactin only requires the
action of ArpP PKS and aminotransferase ArpN, and suggests
that compound 2 suffers a spontaneous cyclization to generate
compound 3. Dehydration and reduction of this compound
would result in the formation of nigrifactin (Figure 5). Moreover,
these results also indicate that the other structural genes in the
cluster (arpDHI, arpDHII, arpHI, arpHII, arpK, and arpO) must
be involved in later steps in the biosynthesis pathway leading to
the formation of argimycins PI/PII, PIV, PV, PVI and PIX.
ArpDHI and ArpDHII show high similarity to several
dehydrogenases. ArpDHI was similar to hypothetical acyl-
CoA dehydrogenases. It contains the Acyl-CoA dehydrogenase,
C-terminal domain (pfam080028). These proteins catalyze
FAD-dependent dehydrogenation steps. It also contains the
conserved protein domain NcnH (cd01159). This is a hydroxylase
involved in the biosynthesis of polyketide naphthocyclinone
that hydroxylates several substrates such as aloesaponarin II
and SEK26 (Brünker et al., 2001). We propose ArpDHI could
hydroxylate the piperidine ring and/or reduce the C7-C8 double
bond of the polyene chain during the biosynthesis of argimycins
P. The identification of argimycin PIX that lacks the C7-C8
double bond in the polyene chain (Figure 3) supports the
existence of a dehydrogenase acting at the polyene chain.
ArpDHII is similar to putative 6-phosphogluconate
dehydrogenases. It belongs to the Rossmann fold
superfamily, and contains the NAD_binding_2 domain of
6-phosphogluconate dehydrogenases (pfam03446) and the
NAD(P) binding domain of Shikimate dehydrogenase (cd01065).
In addition, a Blastp search with ArpDHII using the Protein Data
Bank proteins (PDB) gave significant alignments with several
imine reductases, such as Q1EAE0 (acc. number 3ZGY_A) from
Streptomyces kanamyceticus (Rodríguez-Mata et al., 2013) and
AoIRED (acc. number 5A9S_B) from Amycolatopsis orientalis
(Aleku et al., 2016). We suggest that ArpDHII could be an imine
reductase that catalyzes the reduction of the imine group of
argimycins P.
ArpHI and ArpHII belong to the NTF2_like superfamily,
and contain a SnoaL-like domain (pfam12680 and pfam13474,
respectively). SnoaL is a polyketide cyclase which catalyzes the
last cyclization step during nogalamycin biosynthesis (Sultana
et al., 2004). ArpHI shows similarity to hypothetical proteins,
while ArpHII was similar to several putative hydrolases. In
addition, ArpHI and ArpHII were similar to StzF and StzE,
respectively. These two proteins have recently been proposed
to act as cyclases during streptazone E biosynthesis (Ohno
et al., 2015). We propose ArpHI and ArpHII to be involved
in the formation of the five-membered ring present in some
argimycins P.
ArpO shows high similarity to several putative oxidases. It
contains a NAD(P)-binding Rossmann domain (pfam13450)
and a putative FAD-binding dehydrogenase domain
(PRK12834). Also, it contains domains that belong to the
conserved protein domain families desat_CrtD (TIGR02733)
and CrtI_fam (TIGR02734). These enzymes catalyze
desaturation/dehydrogenation reactions. According to that,
ArpO could carry out dehydrogenation/oxidation reactions
during biosynthesis of argimycins P.
ArpK shows high similarity to flavin reductases, and contains
flavin reductase like domains (smart00903 and pfam01613).
ArpK could be involved in regenerating flavin nucleotides that
could be used by putative dehydrogenases ArpDHI and ArpO.
The arp gene cluster contains two regulatory genes located
at the boundaries of the cluster. arpRI codes for a SARP-
like regulatory protein (Wietzorrek and Bibb, 1997). At its
N-terminus contains a Trans_reg_C (Pfam00486), followed by a
BTAD (Bacterial Transcriptional Activation Domain) (cd158319)
domain; and at its C-terminus, the ATP-binding domain AAA_16
(Pfam13191). ArpRI behaves as a transcriptional activator. Its
inactivation completely blocked argimycins P production, as it
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FIGURE 7 | UPLC chromatograms of butanol extracts of Streptomyces
NRRL S-1022. N, nigrifactin; IV, argimycin PIV; V, argimycin PV; VI, argimycin
PVI.
was shown in S. argillaceus MARPRI (see above). arpRII codes
for a transcriptional regulator belonging to the TetR family
(Ramos et al., 2005). It contains the TetR domain (pfam00440).
As shown above, ArpRII behaves as a transcriptional repressor,
since its inactivation led to an increase in argimycins P
production (S. argillaceus MARPRII). In addition, the arp cluster
contains a gene (arpX), whose product shows high similarity
to hypothetical proteins from different Streptomyces. At this
moment, no role can be assigned to this gene product in
argimycins P biosynthesis.
Most of the arp gene products show high similarity to proteins
from an incomplete and uncharacterized PKS gene cluster in
Streptomyces sp. NRRL S-1022 (Table 3; Supplementary Figure
S37). Specifically, there was high similarity and synteny between
upstream genes of the PKS region, and also with the arpT
gene product. Upstream of arpRI and downstream of arpT, the
similarity is lost, that is in Streptomyces sp. NRRL S-1022 there
are no homologous genes to arpX and arpRII. To determine if
this strain also produces argimycins P, the strain was obtained
from the NRRL culture collection and cultivated. Butanol extracts
of cultures of this strain showed production of argimycin PIII
(nigrifactin), argimycin PIV, argimycin PV and argimycin PVI
(Figure 7). This confirmed that genes arpRI to arpT are sufficient
to synthesize these argimycins P. However, no argimycin PI and
PII was detected (data not shown), reinforcing the hypothesis that
enzymes required for the formation and incorporation of NAC
moiety to these compounds are encoded by genes outside the arp
cluster.
DISCUSSION
The first genome sequences obtained from Streptomyces revealed
that these microorganisms had greater potential to produce
secondary metabolites than expected (Bentley et al., 2002; Ikeda
et al., 2003). The improvement and development of sequencing
technologies and bioinformatic tools has allowed the use of
genome mining as a new and effective approach to discover new
metabolites produced by microorganism, by activating and/or
increasing production of unknown compounds encoded by
cryptic biosynthesis gene clusters (Olano et al., 2014; Rutledge
and Challis, 2015; Ochi, 2016). Genome mining applied to
the antitumor mithramycin producer S. argillaceus has allowed
the identification of 31 gene clusters for the biosynthesis of
secondary metabolites. In addition to the mithramycin gene
cluster, which has been previously characterized (Lombó et al.,
2006), the metabolic products of 11 gene clusters could be
predicted. Cluster 18 (renamed as arp cluster) was related to
the coelimycin P1 and the recently reported streptazone E gene
cluster (Gómez-Escribano et al., 2012; Ohno et al., 2015), and
was predicted to direct the biosynthesis of a PK derived from
the condensation of six malonyl-CoA units. Identification of
compounds encoded by this cluster was carried out by combining
several strategies: (i) inactivation of the type I PKS gene arpPIII to
block production of compounds; (ii) inactivation of the putative
TetR-transcriptional repressor arpRII to increase production of
compounds; (iii) cultivation of wild type and mutant strains
in different production media, to increase production and
identification of compounds; and (iv) use of strains with
increased intracellular amounts of malonyl-CoA, to favor the
biosynthesis of the malonyl-CoA derived PK chain. Using this
combined strategy seven compounds were identified, one of
them, nigrifactin, previously identified in Streptomyces FFD-
101(Terashima et al., 1969). The remaining newly discovered
compounds were named argimycins P. Nigrifactin and argimycin
PIX are simple piperidine alkaloids consisting of a piperidine
ring with a polyene chain attached. They differ in the nitrogen
atom that is reduced in argimycin IX, and in the existence
of a C7-C8 double bond in the polyene chain in nigrifactin
absent in argimycin PIX. Argimycin PIV, argimycin PV and
argimycin PVI differ in their hydroxylation pattern, and contain
a piperidine ring fused to a five-membered ring and a shorter
polyene side chain. They are structurally related to pyrindicin
(Onda et al., 1973) and streptazones E and F (Liu et al.,
2013), and to other alkaloids with shorter side chains such as
abikoviromycin (latumcidin) (Umezawa et al., 1951; Sakagami
et al., 1958). Argimycins PI and PII are isomers, and unlike
argimycins PIV-PVI contain a pyridine ring, and additionally,
they contain a NAC residue attached to the polyene chain.
For some of the piperidine alkaloid compounds structurally
related to argimycins P antimicrobial, cytotoxic and antiviral
activities has been reported (Umezawa et al., 1951; Puder
et al., 2001). In some of these compounds, bioactivity has been
related to the presence of double bonds, an epoxy group, or
an imine group in the piperidine ring, among others (Hegde
et al., 1994; Puder et al., 2000; Maruyama et al., 2003; Liu
et al., 2013). In addition, some of these and related compounds
have been shown to exert other activities such as decreasing
blood pressure, inhibiting biosynthesis of cholesterol or having
analgesic properties (Terashima et al., 1970; Grabley et al., 1991).
Some argimycins P also showed weak antibiotic but no cytotoxic
activity, being argimycin PIII (nigrifactin) the most active one. If
they display other activities is unknown at this time and remains
to be discovered. On the other hand, argimycins P seem to
play a role in growth and colony development in S. argillaceus:
argimycins P non-producer mutants show better growth and
sporulation than producer strains. Therefore, expression of the
arp cluster and/or production of the encoded argimycins P
seem to reduce/decrease colony growth and development in
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S. argillaceus. Further studies will be required to understand the
role of these genes and compounds on these processes.
The boundaries of the arp biosynthesis gene cluster have been
determined by inactivating/deleting genes at both ends of the
cluster. It contains 14 genes, including two coding for regulatory
proteins, 11 for structural proteins and one for a hypothetical
protein. The arp cluster shows high similarity to a partial and
uncharacterized cluster from Streptomyces NRRL S-1022, and
to the recently published stz gene cluster from Streptomyces sp.
MSC090213JE08 (Ohno et al., 2015). The genes arpX and arpRII
are absent in those strains. The hypothetical role of arpX is
unclear. In the case of arpRII, we have shown that codes for a
putative TetR-like repressor of argimycins P biosynthesis, since
its inactivation greatly increases argimycins P production. In the
case of Streptomyces sp. MSC090213JE08, there is no evidence of
argimycin P production, although nigrifactin has been proposed
as a biosynthesis intermediate (Ohno et al., 2015). However,
in this manuscript we have shown that Streptomyces NRRL
S-1022 actually produces most argimycins P, which indicates
that those homologous genes between S. argillaceus and S-
1022 strains are sufficient for the biosynthesis of the piperidine
ring containing argimycin P compounds. The pyridine ring
containing compounds argimycin PI and argimycin PII haven’t
been identified in cultures of S-1022 strain, which might indicate
that enzymes for generating these compounds are encoded by
genes located outside of the arp cluster, and are strain specific.
Based on the structure of argimycins P and on the
bioinformatic analysis of the arp cluster, a pathway for the early
steps in argimycins P biosynthesis is proposed (Figure 5). This
would start by the condensation of six malonyl-CoA units by
PKS ArpP. According to the presence of KR and DH domains
in modules 1 to 3 of ArpP, the first three elongation steps
would be followed by the ketoreduction and dehydration of
the resulting β-keto groups to render trans-double bonds at
the corresponding sites. Considering that the KR domain of
module 4 as well as the DH domains of modules 4 and 5 are
inactive, the resulting PK chain would contain a β-keto group
at C8 and a hydroxyl group at C10. Since module 5 contains
a TR domain, this PK chain would be released to render the
putative aldehyde 1. This compound would be the substrate for
aminotransferase ArpN, rendering the hypothetical product 2
that can spontaneously cyclize to form the piperidine ring. In this
report, we have shown that formation of this ring in S. argillaceus
only requires ArpP and ArpN. We propose that the reaction
product of these enzymes would be compound 3 (Figure 5).
Piperidine compounds with a hydroxyl group at C4 but with a
shorter side chain have been identified in cultures of piperidine-
producing organisms (Grabley et al., 1991; Groenhagen et al.,
2014). Spontaneous dehydration and reduction of compound 3
would render nigrifactin (Figure 5). Its reduction at the C7-C8
double bond and at the imine group by ArpDHI and ArpDHII,
would result in the formation of argimycin PIX. Late biosynthetic
steps would involve formation of the fused five-membered ring
and incorporation of NAC adduct, among others. Candidates for
the cyclization reaction could be ArpHI/ArpHII, which contain
a domain present in the SnoaL cyclase from the nogalamycin
pathway (Sultana et al., 2004), and are similar to two putative
cyclases from the streptazone E pathway (Ohno et al., 2015).
Within the arp cluster there are no candidate genes for formation
and transfer of NAC. Downstream of the cluster, there are two
genes (orf11 and orf9) that were initially proposed to be involved
in this process. However, as mentioned above, inactivation of
these genes did not abolish argimycins PI/PII production. In
coelimycin P1 biosynthesis pathway, Gómez-Escribano et al.
(2012) have hypothesized that incorporation of the NAC adduct
would take place by ring opening of bis-epoxide of a biosynthesis
intermediate via nucleophilic attack of the NAC thiol group. In
the case of argimycins P biosynthesis pathway, it is possible that
ArpO, which is similar to different oxidases, could be involved
in oxidizing the side chain, being the resultant product substrate
for the incorporation of NAC. Future studies would be required
to clarify biosynthetic steps downstream of the formation of
piperidine ring.
CONCLUSION
By genome mining of S. argillaceus we have identified the type
I cryptic arp gene cluster and the encoded argimycins P family
of new compounds, which in addition to antibiotic activity, they
seem to play a role in colony growth and development of this
strain.
Notes in Proof
Very recently, it has been shown that the TR domains of the
PKS and the ω-aminotransferases (which are similar to ArpP-TR
and ArpN respectively) involved in the biosynthesis of polyketide
alkaloids coelimycin P1 and cyclizidine, are responsible for the
release of the polyketide chain as an aldehyde and its subsequent
transamination (Awodi et al., 2016; Peng et al., 2016). On the
other hand, Peng et al. (2016) have shown that 3-hydroxyl-6-
methyl-piperidine (an analog of compound 3) is the substrate for
imine reduction, and it is unstable being readily transformed in a
dehydrated product.
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